The Quantum Insider·4 min read·hard
High Q Technologies Expands Quantum Protein Analysis Platform For Alzheimer's Drug Discovery
M
Matt Swayne
✦AI Summary
Ontario-based startup High Q Technologies is utilizing quantum sensing to improve protein analysis for Alzheimer's drug discovery. Their platform, Fathom, tracks protein movement to help researchers better understand how drugs interact with biological structures.
An Ontario startup is deploying quantum sensing technology to help pharmaceutical researchers better understand how proteins move, something the company says could shorten drug discovery timelines for Alzheimer’s disease and other neurodegenerative disorders.
technologysciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in